Cybin (HELP) Common Equity (2021 - 2024)
Cybin (HELP) reported Common Equity of $172.0 million for Q4 2024, up 93.14% on a YoY basis from $89.0 million in Q1 2024, and down 8.01% quarter-over-quarter from $186.9 million in Q3 2024.
Cybin (HELP) Common Equity (2021 - 2024) Analysis & Trends
Cybin has reported Common Equity for 4 years, with the latest figure at $172.0 million in Q4 2024.
- For the quarter ending Q4 2024, Common Equity rose 93.14% year-over-year to $172.0 million; the trailing twelve-month figure through Dec 2024 stood at $172.0 million (up 93.14% YoY), and the FY2024 full-year result was $216.6 million, changed N/A from the prior year.
- Common Equity for Q4 2024 stood at $172.0 million, down from $186.9 million in the prior quarter.
- The five-year high for Common Equity was $216.6 million in Q1 2024, with the low at $36.1 million in Q3 2023.
- Historically, Common Equity has averaged $105.4 million across 4 years, with a median of $74.8 million in 2021.
- Annual changes were most pronounced in 2022 — Common Equity plunged 41.29% — and 2024, when it jumped 417.97%.
- Cybin's Common Equity stood at $70.7 million in 2021, then slumped by 41.29% to $41.5 million in 2022, then soared by 114.58% to $89.0 million in 2023, then soared by 93.14% to $172.0 million in 2024.
- The last three Common Equity figures came in at $172.0 million (Q4 2024), $186.9 million (Q3 2024), and $204.6 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 171.98 Mn |
| Sep 30, 2024 | 186.94 Mn |
| Jun 30, 2024 | 204.60 Mn |
| Mar 31, 2024 | 216.64 Mn |
| Dec 31, 2023 | 89.04 Mn |
| Sep 30, 2023 | 36.09 Mn |
| Jun 30, 2023 | 50.67 Mn |
| Dec 31, 2022 | 41.49 Mn |
| Sep 30, 2022 | 49.25 Mn |
| Dec 31, 2021 | 70.68 Mn |
| Sep 30, 2021 | 78.96 Mn |
| Mar 31, 2021 | 68.04 Mn |